Are you Dr. Grogan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1501 N Campbell Ave
Tucson, AZ 85724Phone+1 520-694-8888Fax+1 520-626-6081
Summary
- Dr. Thomas Grogan, MD is a board certified pathologist in Tucson, Arizona. He is currently licensed to practice medicine in Arizona and California. He is a Professor at University of Arizona College of Medicine.
Education & Training
- Letterman Army Medical CenterResidency, Pathology-Anatomic and Clinical, 1972 - 1976
- Letterman Army Medical CenterInternship, Internal Medicine, 1971 - 1972
- George Washington University School of Medicine and Health SciencesClass of 1971
Certifications & Licensure
- CA State Medical License 1975 - Present
- AZ State Medical License 1980 - 2023
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Clinical Trials
Publications & Presentations
PubMed
- 125 citationsA phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study.William S. Dalton, John Crowley, S. Salmon, Thomas M. Grogan, Leslie Rodgers Laufman
Cancer. 1995-02-01 - 9 citationsLiver biopsy immunotyping to characterize lymphoid malignancies.Christopher J. Verdi, Thomas M. Grogan, Robert Protell, Lynne Richter, Catherine S. Rangel
Hepatology. 1986-01-01 - 12 citationsTerminal lymphoblastic transformation in polycythemia vera.Theodore A. Braich, Thomas M. Grogan, Mary J. Hicks, Bernard R. Greenberg
The American Journal of Medicine. 1986-02-01
Press Mentions
- A Doctor-Entrepreneur’s Guide to Socially Responsible CapitalismJanuary 31st, 2020
- Arizona: The New Frontier in Technology and Health CareSeptember 18th, 2019
- New Frontiers in Cancer Research and Treatment to Be Explored by Global Experts at Tucson SymposiumFebruary 27th, 2017